These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183 [TBL] [Abstract][Full Text] [Related]
6. Neuroimaging markers of human immunodeficiency virus infection in South Africa. Heaps JM; Joska J; Hoare J; Ortega M; Agrawal A; Seedat S; Ances BM; Stein DJ; Paul R J Neurovirol; 2012 Jun; 18(3):151-6. PubMed ID: 22528474 [TBL] [Abstract][Full Text] [Related]
7. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation. Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452 [TBL] [Abstract][Full Text] [Related]
8. Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood. Ruiz-Saez B; García MM; de Aragon AM; Gil-Correa M; Melero H; Malpica NA; de Ory SJ; Zamora B; Guillen S; Rojo P; Falcon-Neyra L; Alvarez A; Fernandez P; Lorente-Jareño ML; Ramos JT; Sainz T; Velo C; Navarro ML; Gonzalez-Tomé MI; Medicine (Baltimore); 2021 Apr; 100(15):e25403. PubMed ID: 33847637 [TBL] [Abstract][Full Text] [Related]
9. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings. Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435 [TBL] [Abstract][Full Text] [Related]
10. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication. Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816 [TBL] [Abstract][Full Text] [Related]
11. HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy. Kallianpur KJ; Valcour VG; Lerdlum S; Busovaca E; Agsalda M; Sithinamsuwan P; Chalermchai T; Fletcher JL; Tipsuk S; Shikuma CM; Shiramizu BT; Ananworanich J; AIDS; 2014 Jul; 28(11):1619-24. PubMed ID: 25232899 [TBL] [Abstract][Full Text] [Related]
13. Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognition. Lewis-de Los Angeles CP; Williams PL; Huo Y; Wang SD; Uban KA; Herting MM; Malee K; Yogev R; Csernansky JG; Nichols S; Van Dyke RB; Sowell ER; Wang L; Brain Behav Immun; 2017 May; 62():100-109. PubMed ID: 28089557 [TBL] [Abstract][Full Text] [Related]
14. Regional Cerebral Gray Matter Volume in HIV-Positive Patients with Executive Function Deficits. Corrêa DG; Zimmermann N; Netto TM; Tukamoto G; Ventura N; de Castro Bellini Leite S; Cabral RF; Fonseca RP; Bahia PR; Gasparetto EL J Neuroimaging; 2016 Jul; 26(4):450-7. PubMed ID: 26780881 [TBL] [Abstract][Full Text] [Related]
15. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals. Sanford R; Fellows LK; Ances BM; Collins DL JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878 [TBL] [Abstract][Full Text] [Related]
16. Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV. Nir TM; Fouche JP; Ananworanich J; Ances BM; Boban J; Brew BJ; Chaganti JR; Chang L; Ching CRK; Cysique LA; Ernst T; Faskowitz J; Gupta V; Harezlak J; Heaps-Woodruff JM; Hinkin CH; Hoare J; Joska JA; Kallianpur KJ; Kuhn T; Lam HY; Law M; Lebrun-Frénay C; Levine AJ; Mondot L; Nakamoto BK; Navia BA; Pennec X; Porges EC; Salminen LE; Shikuma CM; Surento W; Thames AD; Valcour V; Vassallo M; Woods AJ; Thompson PM; Cohen RA; Paul R; Stein DJ; Jahanshad N JAMA Netw Open; 2021 Jan; 4(1):e2031190. PubMed ID: 33449093 [TBL] [Abstract][Full Text] [Related]
17. Independent effects of HIV, aging, and HAART on brain volumetric measures. Ances BM; Ortega M; Vaida F; Heaps J; Paul R J Acquir Immune Defic Syndr; 2012 Apr; 59(5):469-77. PubMed ID: 22269799 [TBL] [Abstract][Full Text] [Related]
18. Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years. Clifford KM; Samboju V; Cobigo Y; Milanini B; Marx GA; Hellmuth JM; Rosen HJ; Kramer JH; Allen IE; Valcour VG J Acquir Immune Defic Syndr; 2017 Nov; 76(3):289-297. PubMed ID: 28650401 [TBL] [Abstract][Full Text] [Related]
19. Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals. Zhuang Y; Qiu X; Wang L; Ma Q; Mapstone M; Luque A; Weber M; Tivarus M; Miller E; Arduino RC; Zhong J; Schifitto G J Neurovirol; 2017 Oct; 23(5):704-712. PubMed ID: 28791662 [TBL] [Abstract][Full Text] [Related]